Market Access Preparing for the pharma fraud enforcement surge Here is what robust, risk-based compliance looks like in 2026.
News England to start screening newborns for rare disease SMA All newborns in England will be screened for rare muscle-wasting disease spinal muscular atrophy from 2027, in a landmark move for patients.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
